Cargando…
A standardised framework to identify optimal animal models for efficacy assessment in drug development
INTRODUCTION: Poor translation of efficacy data derived from animal models can lead to clinical trials unlikely to benefit patients–or even put them at risk–and is a potential contributor to costly and unnecessary attrition in drug development. OBJECTIVES: To develop a tool to assess, validate and c...
Autores principales: | S. Ferreira, Guilherme, Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563989/ https://www.ncbi.nlm.nih.gov/pubmed/31194784 http://dx.doi.org/10.1371/journal.pone.0218014 |
Ejemplares similares
-
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development
por: Ferreira, Guilherme S., et al.
Publicado: (2019) -
Levelling the Translational Gap for Animal to Human Efficacy Data
por: Ferreira, Guilherme S., et al.
Publicado: (2020) -
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs
por: Ferreira, Guilherme S., et al.
Publicado: (2023) -
Future of the drug label: Perspectives from a multistakeholder dialogue
por: Gispen‐de Wied, Christine C., et al.
Publicado: (2019) -
Immunogenicity of Therapeutic Proteins: The Use of Animal Models
por: Brinks, Vera, et al.
Publicado: (2011)